Xenon Pharmaceuticals XENE Earnings Call Transcripts

NASDAQ XENE
$41.39 +0.94 (+2.32%)
At close: Nov 10, 2026 · 4:00 PM EST
6 earnings calls on file for Xenon Pharmaceuticals, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Xenon Pharmaceuticals Q2 2026 Earnings Call

Aug 6, 2026 8,954 words · 39 min read
  • Colleen AlabisoSenior Vice President of Corporate Affairs
  • Ian MortimerPresident and Chief Executive Officer
  • Christopher KenneyChief Medical Officer
  • Darren ClineChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Xenon Pharmaceuticals Earnings Call Transcripts

Calls6
LatestAug 6, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2020

Fiscal 2019

All 6 Xenon Pharmaceuticals transcripts Register to get access to Xenon Pharmaceuticals’s earnings call transcripts.